Company · CIK 0000882796 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BIOCRYST PHARMACEUTICALS INC · BCRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 AForm 4 → | Sep 2, 4:16 pm EDT | Jon P StonehouseDirector | 644 | $9.70 | $6,247 | 1,340,419 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:13 pm EDT | Jill C. MilneDirector | 1,288 | $9.70 | $12,494 | 33,226 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:10 pm EDT | Vincent MilanoDirector | 1,159 | $9.70 | $11,242 | 109,642 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:06 pm EDT | Amy E McKeeDirector | 644 | $9.70 | $6,247 | 47,821 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 4:04 pm EDT | Steven FrankDirector | 1,288 | $9.70 | $12,494 | 36,747 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.